Every once in a while, a funding round lands that feels less like a headline and more like a mirror held up to an industry that has been pretending not to see its own mess. Alaffia Health just closed a $55M Series B, led by Transformation Capital with FirstMark Capital, Tau Ventures, and Twine Ventures riding shotgun, and the number is big, but the signal underneath it is louder. Healthcare payments have been noisy for decades. This is what it sounds like when clarity starts winning.
TJ Ademiluyi and Adun Akanni did not wake up one morning and decide to disrupt anything. They grew up inside the billing grind, watching how good care gets tangled in bad math, missing context, and systems that reward confusion. That lived reality turned into Alaffia Health in 2020, and into a platform that actually reads the full clinical story instead of skimming the invoice and guessing. Agentic AI for claims operations sounds academic until you realize it is saving health plans real money by understanding medicine the way clinicians do.
This Series B brings total funding north of $73M, but more important, it validates a model that pairs machines with judgment. Alaffia Health’s platform forensically evaluates claims against complete medical records, runs with over 97% accuracy, and delivers more than 5x ROI for health plans. That is not a vanity metric. That is operational truth showing up on a balance sheet. More than $100M in cumulative savings already says the tech works. The additional capital says the market is ready to scale it.
The bench matters here. Oyinade Famuyiwa, Pharm.D., VP of Payment Integrity Operations, running payment integrity operations with clinical rigor, and Ron Jones, VP of Complex Claims Solutions, bringing 20+ years of scar tissue from complex claims, are why this does not feel theoretical. On the board, Todd Cozzens, Managing Partner at Transformation Capital, joins Amish Jani, Founder and Partner at FirstMark Capital, and that mix of operating depth and disciplined growth experience is exactly what this stage demands.
There is also a quiet confidence in the move to a 7,462 sq ft space at 446 Broadway, 2nd Floor, SoHo, on a 6-year lease. Not flashy. Functional. Built for a team that doubled in 2025 because demand did not politely wait. The lesson for founders paying attention is not about chasing AI buzzwords. It is about picking a brutal, unsexy problem, learning it end to end, and then building something defensible enough that grown up capital wants to stay for the long haul.
For health plans drowning in high-cost claims, appeals backlogs, and weeks-long turnaround times, Alaffia Health is not selling magic. It is selling time, accuracy, and confidence. In a system where 80% of claims carry errors and billions leak out quietly every year, that is not just a product. That is leverage, and leverage changes conversations.
